USD 7.41
(19.71%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 8.2 Million USD | -30.38% |
2022 | 11.78 Million USD | -19.78% |
2021 | 14.69 Million USD | 1033.8% |
2020 | 1.29 Million USD | -81.91% |
2019 | 7.16 Million USD | 0.0% |
2018 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | 5.44 Million USD | 0.0% |
2024 Q1 | 7.29 Million USD | 0.0% |
2024 Q2 | 6.36 Million USD | 0.0% |
2023 Q1 | 10.85 Million USD | -7.95% |
2023 FY | 8.2 Million USD | -30.38% |
2023 Q4 | 8.2 Million USD | -9.69% |
2023 Q3 | 9.08 Million USD | -9.09% |
2023 Q2 | 9.99 Million USD | -7.88% |
2022 Q2 | 12.84 Million USD | -6.38% |
2022 Q1 | 13.71 Million USD | -6.65% |
2022 FY | 11.78 Million USD | -19.78% |
2022 Q4 | 11.78 Million USD | -3.45% |
2022 Q3 | 12.2 Million USD | -4.94% |
2021 FY | 14.69 Million USD | 1033.8% |
2021 Q4 | 14.69 Million USD | -1.96% |
2021 Q3 | 14.98 Million USD | 1831.44% |
2021 Q2 | 776 Thousand USD | -20.0% |
2021 Q1 | 970 Thousand USD | -25.15% |
2020 Q1 | 5.64 Million USD | -21.15% |
2020 Q4 | 1.29 Million USD | -57.59% |
2020 Q3 | 3.05 Million USD | -24.32% |
2020 Q2 | 4.03 Million USD | -28.52% |
2020 FY | 1.29 Million USD | -81.91% |
2019 FY | 7.16 Million USD | 0.0% |
2019 Q4 | 7.16 Million USD | 0.0% |
2018 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Doximity, Inc. | 12.39 Million USD | 33.807% |
Evolent Health, Inc. | 635.05 Million USD | 98.708% |
MultiPlan Corporation | 4.53 Billion USD | 99.819% |
Phreesia, Inc. | 2.04 Million USD | -300.488% |
Teladoc Health, Inc. | 1.58 Billion USD | 99.481% |
Veeva Systems Inc. | 46.44 Million USD | 82.33% |